Back to Search
Start Over
Recombinant factor VIIa versus aPCCs in haemophiliacs with inhibitors: treatment and cost considerations.
- Source :
-
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 1999 Sep; Vol. 5 Suppl 3, pp. 43-9. - Publication Year :
- 1999
- Subjects :
- Blood Coagulation Factors economics
Blood Coagulation Factors immunology
Blood Coagulation Factors standards
Consumer Product Safety
Costs and Cost Analysis
Factor VIIa economics
Factor VIIa standards
Hemophilia A economics
Humans
Recombinant Proteins economics
Recombinant Proteins standards
Recombinant Proteins therapeutic use
Blood Coagulation Factors therapeutic use
Factor VIIa therapeutic use
Hemophilia A drug therapy
Isoantibodies adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1351-8216
- Volume :
- 5 Suppl 3
- Database :
- MEDLINE
- Journal :
- Haemophilia : the official journal of the World Federation of Hemophilia
- Publication Type :
- Academic Journal
- Accession number :
- 10597387
- Full Text :
- https://doi.org/10.1046/j.1365-2516.1999.00037.x